Longer survival with higher doses of thoracic radiotherapy in patients with limited non-small cell lung cancer
Authors:
- Jane MatthewsJMJane Matthews
- Valentina WorotniukVWValentina Worotniuk
- Elizabeth CrennanECElizabeth Crennan
- 1 March 1993
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 25 (4) , 599-604
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Concurrent Radiotherapy and Carboplatin in Non Small-Cell Lung Cancer: A Pilot Study Using Conventional and Accelerated FractionationAustralasian Radiology, 1991
- A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung CancerNew England Journal of Medicine, 1990
- A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.Journal of Clinical Oncology, 1990
- Thoracic Radiotherapy Does Not Prolong Survival in Patients with Locally Advanced, Unresectable Non-Small Cell Lung CancerAnnals of Internal Medicine, 1990
- Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology groupCancer, 1987
- COMPARISON OF TREATMENT POLICIES IN INOPERABLE BRONCHIAL CARCINOMAThe Lancet, 1971
- The Survival of Patients with Inoperable Lung Cancer: A Large-Scale Randomized Study of Radiation Therapy Versus PlaceboRadiology, 1968